We are live on
!
Find out more
Group One Trading Portfolio holdings
AUM
$52.2B
1-Year Est. Return
104.56%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,999.92%
AUM
$9.21B
AUM Growth
+$762M
(+9%)
Cap. Flow
+$86.4M
Cap. Flow
% of AUM
0.94%
Top 10 Holdings %
Top 10 Hldgs %
10.76%
Holding
5,470
New
864
Increased
1,681
Reduced
1,705
Closed
949
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$33M |
| 2 |
iShares Silver Trust
SLV
|
+$27.5M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$22.6M |
| 4 |
United Parks & Resorts
PRKS
|
+$15.6M |
| 5 |
TSL
Trina Solar Limited
TSL
|
+$14.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$28.1M |
| 2 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$22.3M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$17.3M |
| 4 |
AbbVie
ABBV
|
+$13.5M |
| 5 |
MBLY
Mobileye N.V.
MBLY
|
+$9.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.15% |
| 2 | Materials | 1.9% |
| 3 | Technology | 1.65% |
| 4 | Consumer Discretionary | 1.6% |
| 5 | Energy | 1.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FGP
1651
DELISTED
Ferrellgas Partners, L.P.
FGP
| $556K | 0.01% |
+47,808
| New | +$894K |
|
1652
PUT
Ciena
CIEN
$57.2B
| $554K | 0.01% |
25,400
+600
| +2% | +$12.5K |
|
1653
CALL
Genesis Energy
GEL
$1.86B
| $554K | 0.01% |
14,600
-46,600
| -76% | -$1.71M |
|
1654
CALL
VOC Energy
VOC
$50.7M
| $554K | 0.01% |
185,900
+100,000
| +116% | +$310K |
|
1655
RH
RH
$3.56B
| $553K | 0.01% |
+15,985
| New | +$509K |
|
1656
Celldex Therapeutics
CLDX
$3.26B
| $551K | 0.01% |
9,089
-1,926
| -17% | -$120K |
|
1657
Energous
WATT
$98.5M
| $551K | 0.01% |
+47
| New | +$419K |
|
|
FNSR
1658
PUT
DELISTED
Finisar Corp
FNSR
| $551K | 0.01% |
18,500
-100
| -0.5% | -$2.19K |
|
1659
PUT
Marriott Vacations Worldwide
VAC
$4.28B
| $550K | 0.01% |
7,500
+800
| +12% | +$59.4K |
|
|
ACHN
1660
CALL
DELISTED
Achillion Pharmaceuticals
ACHN
| $550K | 0.01% |
67,900
-70,800
| -51% | -$602K |
|
1661
Cemex
CX
$16.3B
| $549K | 0.01% |
71,973
-86,638
| -55% | -$638K |
|
|
DFS
1662
CALL
DELISTED
Discover Financial Services
DFS
| $549K | 0.01% |
9,700
-37,100
| -79% | -$2.13M |
|
1663
CALL
Oramed Pharmaceuticals
ORMP
$179M
| $548K | 0.01% |
75,500
| – | – |
|
1664
ConocoPhillips
COP
$142B
| $547K | 0.01% |
12,576
-6,499
| -34% | -$270K |
|
1665
Agios Pharmaceuticals
AGIO
$1.91B
| $545K | 0.01% |
10,310
-3,297
| -24% | -$144K |
|
1666
PUT
Akebia Therapeutics
AKBA
$256M
| $545K | 0.01% |
60,200
+16,800
| +39% | +$143K |
|
1667
PUT
Boston Properties
BXP
$11B
| $545K | 0.01% |
+4,000
| New | +$555K |
|
1668
VEON
VEON
$3.87B
| $545K | 0.01% |
+6,259
| New | +$629K |
|
1669
PUT
Yum! Brands
YUM
$41.6B
| $545K | 0.01% |
8,346
-87,355
| -91% | -$5.58M |
|
|
NEWR
1670
CALL
DELISTED
New Relic, Inc.
NEWR
| $544K | 0.01% |
14,200
+10,200
| +255% | +$358K |
|
1671
ClearSign Technologies
CLIR
$26.1M
| $543K | 0.01% |
9,043
+8,723
| +2,726% | +$433K |
|
|
DBD
1672
PUT
DELISTED
Diebold Nixdorf Incorporated
DBD
| $543K | 0.01% |
21,900
+7,600
| +53% | +$202K |
|
|
QUNR
1673
CALL
DELISTED
Qunar Cayman Islands Limited
QUNR
| $542K | 0.01% |
18,700
-145,000
| -89% | -$4.28M |
|
1674
CALL
Las Vegas Sands
LVS
$29.9B
| $541K | 0.01% |
9,400
-5,400
| -36% | -$278K |
|
1675
Warner Bros
WBD
$66.2B
| $541K | 0.01% |
20,109
-11,810
| -37% | -$303K |
|
Similar funds
SCP
Group One Trading's Q3 2016 Portfolio in Review
As of Q3 2016, Group One Trading held 5,470 positions worth $9.21B, up 9% from $8.45B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Group One Trading's Q3 2016 filing shows 864 new, 1,681 increased, 1,705 reduced and 949 closed positions. Its largest new stake was Pfizer: 313,934 shares worth $10.1M. The largest sale was Allergan plc, an estimated $28.1M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.8% a quarter earlier, followed by Materials and Technology.
- Group One Trading's largest Q3 2016 buy was Pfizer: 313,934 shares worth $10.1M.
- Group One Trading added most to Humana in Q3 2016, an estimated $33M increase.
- Group One Trading's biggest Q3 2016 reduction was Allergan plc, cutting an estimated $28.1M.
- Group One Trading fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $22.3M.
- Group One Trading's ten largest holdings make up 11% of its $9.21B portfolio in Q3 2016.
- Group One Trading opened 864 new positions and closed 949 in Q3 2016.
- Group One Trading's portfolio value rose 9% quarter-over-quarter to $9.21B.
Based on Group One Trading's 13F filing for Q3 2016, filed 14 Nov 2016.